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Dear Editor,
DNA-damaging anti-cancer drugs cause cell death by
apoptosis, but they also activate macroautophagy1 (hereafter
just autophagy), a fundamental survival pathway under stress
where cells enclose cytosol or organelles in double-mem-
brane autophagosomes, then fuse them with lysosomes for
recovery of metabolic precursors.2 This process depends
upon autophagy-related (ATG) proteins.2 Activation of
this survival pathway is unwanted in cancer therapy,
because even a few surviving tumor cells can accumulate
mutations, gain genetic diversity, and, potentially, resume
proliferation.3
We recently reported that expression of ATG5 was
upregulated by treatment with low concentrations of etopo-
side.4 Few cells entered apoptosis, but almost all showed
autophagy. Surprisingly, much of the induced ATG5 was
found in the cell nucleus, binding to BIRC5/survivin and
causing cell cycle arrest at G2/M followed by mitotic
catastrophe.4,5 We then asked whether just ectopic ATG5
expression, without etoposide, would lead to mitotic cata-
strophe. Indeed, a large part of the expressed ATG5 was
again found in the nucleus and rapid cell cycle arrest together
with mitotic catastrophe was observed.4 DNA damage,
however, was not in evidence; neither ATM nor ATR
phosphorylation was detected and foci of H2AX phosphoryla-
tion were absent.4 This has led us to ask: how can ATG5
induce the same kind of stress response as DNA-damaging
drugs?
This report documents increased p53 expression after
lentivirus-mediated, ectopic ATG5 expression (Figure 1a).
Upregulated p21 demonstrated p53 transactivation of a target
gene. Vector alone elicited only a slightly elevated p53. As
expected, ATG5 expression also caused autophagy as
measured by lipidated LC3 (LC3-II).
One wonders whether the observed p53 upregulation/
activation is necessary to initiate autophagy?6 Using p53 null
Saos-2 cells made DOX inducible for p53 with a Tet-on
construct, we showed that p53 was not required for
autophagy (Figure 1b). Ectopically expressed ATG5 is
shown as both 33-kDa monomer and 57-kDa conjugate with
ATG12. Autophagy was apparent from LC3-II. An additional
stimulus with nutrient starvation was followed within 1 h by
further increased LC3-II, but without any requirement for p53
induction (Figure 1b).
As lentivirus-mediated gene transfer might have produced
some local anomalies in DNA, we studied p53 expression/
activation in an ATG5 knockout mouse embryo fibroblast
(mEF) line that had been subsequently transfected with a
Tet-off ATG5 expression system (clone M5-7).7 As these
cells had been maintained since 2006 without DOX
stimulation, a DNA damage response seems unlikely;
however, we examined ATM phospho-Ser1981 as confirma-
tion (Figure 1c). After DOX treatment, ATG5 expression in
these cells was rapidly suppressed. Note: please ignore the
unspecific band seen in mEF cells at 36 kDa. In mEF cells,
ATG5 exists almost entirely as a conjugate with ATG12.
Corresponding to the downregulation of ATG5 after DOX,
both p53 expression and autophagy, monitored as LC3-II
levels, declined sharply (Figure 1c). Also in Figure 1d, using
the same Tet-off ATG5 expression system, these differences
between ATG5-non-expressing and ATG5-expressing cells
were apparent. Noteworthy is that, ATG5-expressing
cells showed not only elevated p53 levels, but also increased
p53 activation as evidenced by p53 Ser18 phosphorylation
(Figure 1d). Interestingly, starvation also induced p53 in
DOX-treated cells not expressing ATG5, not, however,
LC3-II or autophagy.
Our findings thus indicate that increased ATG5 expression
represents for the cell something like a stress response. In
consequence, p53 upregulation and transactivation of p21 are
followed by cell cycle arrest. Here p53 is not acting in its
generally accepted role as a regulator of autophagy and
apoptosis,6 but itself exhibits a secondary response to
upregulation of ATG5 expression. Similar findings have been
reported recently with ATG7 knockout mEF cells,8 showing
that ATG7 also can impose a reciprocal regulation on p53.
Surprisingly too, activation of the NF-kB pathway, an
important stress response, is blocked in cells lacking either
ATG5 or ATG7.9 All these observations suggest a network of
interactive responses available to the cell, initiated by different
homeostatic imbalances, but integrated in the same overall
program.
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Figure 1 ATG5 expression induces and activates p53. (a) Jurkat T cells were transduced with lentivirus constructs of vector alone or ATG5. Here shown is the ATG5
33-kDa monomer band. At the indicated intervals in hours, lysates were prepared, electrophoresed and processed for immunoblotting with the respective antibodies as shown
to the right of each panel. Molecular weights are indicated on the left. GAPDH served as a loading control. ‘C’ designates an untransduced control. (b) Saos-2 cells, DOX
inducible for p53, were all transduced with the ATG5 lentivirus construct. After 24 h, half the cultures received DOX and all were incubated a further 24 h. Control cultures
remained in standard medium, whereas all others were starved for the final hour in amino acid-free medium before being processed for immunoblotting as in a. Chloroquine
(CQ) was used as a control for the effect of blocked lysosomal function. (c) The M5-7 clone of mEF cells suppressed ATG5 production upon DOX treatment. Cultures were
untreated or DOX-treated for the indicated intervals and, in all samples, subjected to amino-acid starvation during the final hour before lysis and processing for immunoblotting.
(d) M5-7 cells were untreated or treated with DOX for 120 h. In each group, one control remained in standard medium; all others were starved for the final hour before lysis and
processing for immunoblotting. CQ and 3-methyl adenine (MA) were employed as controls. All data are representative for at least three independent experiments
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